Oncology decision support at the point of care

A digital platform designed for health systems to standardize care and support evidence-based cancer treatment decisions using personalized pathways and flexible EHR-integrated capabilities.

Powered by

Product Overview

Complex care doesn’t need to feel complex


 

For clinicians

Fragmented health systems and evolving guidance make decisions harder to structure and validate. Solavia Decision Suite brings clarity to that process, supporting guided, evidence-based treatment within the care team’s workflow.

 


 

For the organization

Reliable data and consistent care are difficult to achieve without additional burden. Solavia Decision Suite aligns care delivery with structured insight to support quality, compliance, and visibility.

 

From evidence to real-world practice

Solavia Decision Suite provides current, evidence-based guidance for consistent, high-quality care

  • Actionable at the point of care

    • Go from decision-making to placing orders within the EHR
    • Reduce duplicate entry and system switching during visits
    • Keep decisions, orders, and documentation aligned
  • Patient-specific decision support

    • Navigate pathways tailored to patient context
    • Surface relevant treatments, including clinical trials
    • Receive clear rationale and actionable information
  • Trusted, continuously updated content

    • Developed with leading academic cancer centers
    • Grounded in the best available evidence
    • Version-controlled updates ensure consistency
  • Analytics and organizational insight

    • Track pathway adherence, variation, and outcomes
    • Generate reliable data without added clinician burden
    • Support quality initiatives, reporting, and reimbursement

How it works

  1. 1

    Start from the EHR

    Full integration with the EHR enables providers to launch the platform from within patient context
    Start from the EHR
  2. 2

    Navigate and decide

    Explore pathways, review guidance, compare treatment options, and understand rationale
    Navigate and decide
  3. 3

    Deliver care

    Access mapped protocols and available clinical trials in your system
    Deliver care
  4. 4

    Get actionable outputs

    Generate treatment summaries, patient-ready consent forms, and actionable data
    Get actionable outputs
Start from the EHR
Navigate and decide
Deliver care
Get actionable outputs
Solavia integrates seamlessly within our medical record and always provides uniform care delivery across our broad network of hospital and community-based clinicians. Cancer therapy is evolving rapidly, and this allows our physicians to remain up to date on the latest evidence-based therapies. A few quick clicks based on the patient’s disease and disease specific characteristics guides the physician through evidence-based treatment pathways. Solavia can save time for the busy oncologist who can rely on a platform developed by disease content experts.
Michael Grossbard, MD
Deputy Director, Division of Hematology and Oncology
NYU Langone Health

Frequently Asked Questions

Find answers to common questions about our platform and services.

About Solavia

Is Solavia using the same Dana-Farber oncology pathways content as before?

Yes. Solavia continues to use the same evidence-based oncology pathways developed in partnership with Dana-Farber Cancer Institute. The content, curation process, and clinical rigor remain unchanged.

Who creates and maintains Solavia's oncology pathways?

Solavia’s pathways are developed and maintained by a multidisciplinary team of oncology experts in collaboration with leading academic cancer centers, overseen by the Dana-Farber Cancer Institute.

How does Solavia integrate into the clinician's workflow?

Solavia integrates directly with your EHR system, allowing clinicians to launch the platform from within the patient record without switching applications or re-entering data.

How often are the pathways updated?

Expert multi-institutional pathways committees are scheduled to meet 2-4 times/year for each disease to review new FDA actions, publications, presentations and system usage data. In addition, committees meet on an ad hoc basis to address urgent game-changing developments that should not wait until a scheduled meeting.

How does Solavia incorporate the latest evidence, guidelines, and clinical trials?

Our clinical content team monitors FDA actions, major presentations, and the peer-reviewed literature continuously. New evidence is evaluated, reviewed by clinical experts, and incorporated into pathways through a structured update process.

How are pathways validated and reviewed?

All pathways undergo a rigorous multi-step review process involving oncology specialists, clinical pharmacists, and evidence-based medicine experts before publication.

How does Solavia support shared decision-making with patients?

Solavia generates patient-ready materials including treatment summaries and consent forms that clinicians can use to facilitate informed conversations with patients about their care options.

At what points in the care pathway is Solavia designed to be used (e.g., initial diagnosis, tumor board, treatment changes)?

Solavia is designed to support clinicians at multiple touchpoints: initial diagnosis and staging, tumor board preparation, treatment selection, and ongoing treatment monitoring and changes.

How long does it typically take to use Solavia during a visit?

Most clinicians complete pathway navigation in under two minutes. Solavia is designed to support clinical decision-making efficiently, helping integrate evidence-based guidance into the visit without disrupting workflow.

Getting Started

How long does implementation typically take?

Implementation timelines vary based on EHR complexity and institutional requirements, but most health systems go live within 8–12 weeks of contract signing.

What training and onboarding support is provided?

Solavia provides comprehensive onboarding including live training sessions, on-demand video resources, and dedicated customer success support throughout the implementation and go-live period.

Clinical Content

Which cancer types and tumor boards are covered?

Solavia covers a broad range of solid tumors and hematologic malignancies, including breast, lung, colorectal, prostate, and hematologic cancers. Coverage is continuously expanding based on clinical need and partner input.

Will my existing integrations and configurations carry over?

Yes. Existing EHR integrations, institutional customizations, and configurations will be migrated to the Solavia platform as part of the transition process.

Are clinical trials surfaced within the pathway recommendations?

Yes. Relevant clinical trials available at your institution are surfaced within pathway recommendations, making it easy for clinicians to identify and discuss trial eligibility with patients.

Features & Functionality

Does Solavia support analytics and reporting for administrators?

Yes. Solavia provides administrators with dashboards and reports on pathway adherence, treatment variation, and outcomes data, supporting quality initiatives and reimbursement reporting.

Can Solavia generate patient-facing materials?

Yes. Solavia can generate patient-ready treatment summaries and consent forms directly from the pathway session, reducing administrative burden and supporting informed consent workflows.

Technology & Integration

Which EHR systems does Solavia integrate with?

Solavia integrates with major EHR platforms including Epic, Cerner, and others via HL7 FHIR standards. Contact us to discuss your specific EHR environment.

Is Solavia HIPAA compliant and how is data secured?

Yes. Solavia is fully HIPAA compliant. Data is encrypted in transit and at rest, access is role-based, and the platform undergoes regular security audits and penetration testing.

Contact Us

Find out how you can bring Solavia into your workflow

We’ll look at your workflow together and explore how to best support your team.

Solavia Decision Suite is a clinical decision support tool intended to provide evidence-based information and pathway guidance to healthcare professionals. All treatment decisions remain the sole responsibility of the treating clinician.